dapsone has been researched along with cgp-56697 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, DJ; Chimpeni, P; Hughes, DA; Kayange, N; Lalloo, DG; Molyneux, ME; Montgomery, J; Mukaka, M; Ward, SA; Winstanley, PA; Wootton, D | 1 |
| Kaye, DK; Mutyaba, TS; Ndeezi, G; Nshemerirwe, R | 1 |
| Adiamoh, M; Bisseye, C; Cheung, YB; Conway, D; Diatta, M; Dunyo, S; Janha, R; Milligan, P; Njie, F; Nwakanma, D; Sesay, S; Sirugo, G; Sisay Joof, F; Snell, P; Temple, B; Walton, R | 1 |
| D'Alessandro, U; Donegan, S; Tudur Smith, C; Williamson, P | 1 |
3 trial(s) available for dapsone and cgp-56697
| Article | Year |
|---|---|
Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Dapsone; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria; Malawi; Male; Medication Adherence; Plasma; Proguanil; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2009 |
A randomized clinical trial comparing safety, clinical and parasitological response to artemether-lumefantrine and chlorproguanil-dapsone in treatment of uncomplicated malaria in pregnancy in Mulago hospital, Uganda.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Dapsone; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Proguanil; Uganda; Young Adult | 2008 |
Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia.
Topics: Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Aryl Hydrocarbon Hydroxylases; Case-Control Studies; Child; Cytochrome P-450 CYP2C19; Dapsone; Drug Combinations; Ethanolamines; Female; Fluorenes; Gambia; Genotype; Glucosephosphate Dehydrogenase; Hemoglobins; Humans; Incidence; Infant; Malaria; Male; Parasites; Patient Compliance; Proguanil; Treatment Failure; Treatment Outcome | 2011 |
1 other study(ies) available for dapsone and cgp-56697
| Article | Year |
|---|---|
Assessing the consistency assumption by exploring treatment by covariate interactions in mixed treatment comparison meta-analysis: individual patient-level covariates versus aggregate trial-level covariates.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Dapsone; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Meta-Analysis as Topic; Models, Statistical; Outcome Assessment, Health Care; Proguanil; Quinolines; Regression Analysis | 2012 |